GRTS gritstonebio.com: Projected Price to Earnings

GRTS (Gritstone bio, Inc.) - company brandmark

Liquidity shortages and the scaling back of programs to facilitate colorectal cancer vaccine trials create a risk of capital freeze, which is confirmed by the forward P/E NTM of Gritstone bio, Inc. (GRTS). The value of 0.00 reflects this status. Optimism is supported by AI platforms for neoantigen discovery, a strong reputation among oncologists, and the implementation of precise personalized immunotherapy methods for priming the body.

Gritstone bio, Inc. - GRTS Future Price to Earnings Multiple (period 07/04/2022 - 11/02/2024)

Metric breakdowns and analytics for gritstonebio.com (GRTS)

- stock quotes and analyst forecast:
Fundamental company analysis:Gritstone bio Inc. GRTS
Signature product of Gritstone bio, Inc.

To find a balance between asset quality and cost, an investor must evaluate the discounted value of expected cash flows, which measures market optimism through the price-to-earnings ratio. In the case of Gritstone bio, Inc. (GRTS), the company's current forward P/E reflects market confidence in the commercialization of the EDGE AI platform and mRNA vaccines, capturing overvaluation risks should the cost of capital shift.

Analysis of competing companies

Forward P/E Multiple IBRX|Immunocore Holdings plc (IMCR) - Forward Price to Earnings Multiple|Janux Therapeutics Inc - Projected Price to Earnings|Arcus Biosciences (RCUS) - Projected Price to Earnings Ratio|ZYME: Projected Price to Earnings|Future Price to Earnings Multiple TNGX (Tango Therapeutics, Inc.)|IOVA: Forward P/E Multiple|IMTX - Market Cap to Projected Earnings|Future Price to Earnings xencor.com|Projected Price to Earnings compasstherapeutics.com (CMPX)|Future Price to Earnings Replimune Group Inc (REPL)|Projected Price to Earnings Lyell Immunopharma Inc LYEL|Innate Pharma SA - Projected Price to Earnings|Forward P/E Multiple Pyxis Oncology, Inc. PYXS|CGEN - Future Price to Earnings|IOBT (iobiotech.com) - Price to Future Earnings Ratio|Sutro Biopharma, Inc (STRO) - Future Price to Earnings|Projected Price to Earnings Ratio MiNK (INKT)|Projected Price to Earnings HOWL|IMMX - Forward Price to Earnings Multiple|Projected Price to Earnings ALXO (ALX Oncology Holdings)|CUE (Cue Biopharma) - Future Price to Earnings Multiple|Forward P/E Multiple PDSB (PDS Biotechnology)|Future Price to Earnings Multiple SONN|MAIABiotech.com - Forward P/E Multiple|Projected Price to Earnings Ratio Liminatus|Lava Tx (LVTX) - Future Price to Earnings|NextCure, Inc. - Future Price to Earnings Multiple|LPTX (Leap Tx) - Forward P/E Multiple|Forward P/E Multiple intensitytherapeutics.com|Future Price to Earnings senseibio.com (SNSE)|TOVX: Price to Expected Earnings Ratio|Forward P/E Multiple KA (kinetabio.com)|neximmune.com (NEXI) - Projected Price to Earnings Ratio|TSBX: Projected Price to Earnings|VCNX: Future Price to Earnings|HARP: Forward P/E Multiple